|
GR1009419B
|
|
Ophthalmic pharmaceutical composition containing a combination of brinzolamide and brimonidine and method of preparation thereof
|
|
GR1009406B
|
|
Pharmaceutical composition comprising vildagliptin and method of preparation thereof
|
|
GR1009392B
|
|
Pharmaceutical composition comprising a peptide drug and method for the preparation thereof
|
|
GR1009209B
|
|
Pharmaceutical composition comprising an antiemetic agent and method for the preparation thereof
|
|
GR1009149B
|
|
Pharmaceutical fomula comprising a fumaric acid ester - production method thereof
|
|
GR1009230B
|
|
Pharmaceutical prasugrel besylate-containing formula
|
|
GR1007973B
|
|
Novel n-oxyiminium compounds as intermediates of an improved process for the preparation of 2,3-diaryl-5-substituted pyridines
|
|
GR1007907B
|
|
Pharmaceutical composition containing a phenocarbamate acetylcholinesterase inhibitor
|
|
GR1007906B
|
|
Ophthalmic pharmaceutical composition containing a carbonic anhydrase inhibitor and method for the preparation thereof
|
|
GR1007881B
|
|
Ophthalmic pharmaceutical composition containing dorzolamide and timolol and method for the preparation thereof
|
|
GR1007802B
|
|
Process for the preparation of bromopyrimidine derivative
|
|
GR1007725B
|
|
Process for the preparation of highly pure duloxetine hydrochloride
|
|
GR1007722B
|
|
Process for the preparation of aripirazole
|
|
GR1007770B
|
|
Pharmaceutical repaglinide-containing solution and preparation method thereof
|
|
GR1007712B
|
|
Pharmaceutical composition containing leukotriene receptor antagonist and method for the preparation thereof
|
|
GR1007628B
|
|
Pharmaceutical composition containing an antimuscarinic agent and method for the preparation thereof
|
|
GR1007767B
|
|
Prolonged release pharmaceutical composition comprising galantamine and method for the preparation thereof.
|
|
GR1007744B
|
|
Pharmaceutical composition comprising an isoxazole antireumatic agent and method for the preparation thereof
|
|
GR1007629B
|
|
Controlled-release pharmaceutical formulation of a non-ergoline dopamine agonist
|
|
GR1007741B
|
|
Pharmaceutical composition containing an atypical antipsychotic agent and method for the preparation thereof
|
